Findings of a study examining marijuana’s neurocognitive effects “suggest that prescribed medical cannabis may have minimal acute impact on cognitive function among patients with chronic health conditions”—which may come as a relief to long-term cannabis patients who are concerned about potential neurological drawbacks of the drug. Authors of the report, published last month in the […]| Marijuana Moment
A new study into the therapeutic effects of psilocybin suggests that use of the psychedelic drug can help ease psychological distress in people who had adverse experiences as children. Researchers said psilocybin appeared to offer “particularly strong benefits to those with more severe childhood adversity.” The study surveyed 1,249 people in Canada, ages 16 and […]| Marijuana Moment
Psilocybin use is associated with “persisting reductions” in depression, anxiety, alcohol misuse—as well as increases in emotional regulation, spiritual wellbeing and extraversion—according to a new study. Researchers at Johns Hopkins University, Ohio State University and Unlimited Sciences said their work represents the “largest prospective survey of naturalistic psilocybin use to date,” finding evidence that supports […]| Marijuana Moment
While using psilocybin mushrooms or LSD can provide enjoyable sensations and useful insights, such trips can sometimes come with uncomfortable effects—including intense grief and fear. But pairing psychedelics with a small dose of MDMA, a new study says, seems to both reduce those feelings of discomfort and highlight more positive aspects of the experience. The […]| Marijuana Moment
Several studies have found psilocybin to be safe and effective in treating substance use disorders—but a first-of-its-kind analysis released on Monday is offering novel insights into exactly how psychedelic-assisted therapy works for people addicted to alcohol. Researchers at NYU, UC San Francisco and the mental health practitioner training provider Fluence set out to investigate the […]| Marijuana Moment
A top federal health agency is soliciting proposals for a series of research initiatives meant to explore how psychedelics could be used to treat drug addiction, with plans to provide $1.5 million in funding to support relevant studies. As public interest in the therapeutic potential of psychedelics continues to grow, the National Institute on Drug […]| Marijuana Moment
A new peer-reviewed study in the journal Nature says treatment with MDMA reduced symptoms in patients with moderate to severe PTSD. The Phase 3 trial findings mean federal regulators could consider approving the drug for wider use as soon as next year, says the Multidisciplinary Association for Psychedelic Studies (MAPS), which sponsored the research. “Thanks […]| Marijuana Moment